Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ictyogroup is a France-based animal health company focused on aquaculture, particularly tilapia health, and on vaccine adjuvant technologies for production animals. Through its operating activities presented under the Ictyodev brand, the company develops tilapia vaccines and feed additives, offers diagnostic services, and provides contract research and contract manufacturing support for vaccine testing and batch release. The company also develops injectable oil adjuvants and mass-vaccination approaches, including oral, mucosal, and in-ovo applications for animal vaccines. In 2020, Virbac acquired a range of Ictyogroup tilapia vaccines and entered a long-term partnership for further tilapia vaccine and formulation development. Overall, Ictyogroup appears to be a small but active specialized animal-health platform company serving the global aquaculture market from France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ictyogroup.